Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
Background. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association betwee...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/9343475 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566151839744000 |
---|---|
author | Runzhen Chen Chen Liu Peng Zhou Yu Tan Zhaoxue Sheng Jiannan Li Jinying Zhou Yi Chen Li Song Hanjun Zhao Hongbing Yan |
author_facet | Runzhen Chen Chen Liu Peng Zhou Yu Tan Zhaoxue Sheng Jiannan Li Jinying Zhou Yi Chen Li Song Hanjun Zhao Hongbing Yan |
author_sort | Runzhen Chen |
collection | DOAJ |
description | Background. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association between postprocedural hsCRP and mortality in patients with acute coronary syndromes (ACS) treated by percutaneous coronary intervention (PCI). Methods. A total of 3940 consecutive ACS patients treated by PCI with postprocedural hsCRP measurements were retrospectively recruited. Patients were stratified into 5 groups according to quintiles of hsCRP. Cox regression with adjustments for multiple covariates was used for outcome analysis. Restricted cubic spline (RCS) analysis was used to allow possible nonlinear associations. The primary outcome was all-cause death. Results. During a median follow-up of 727 days, mortality occurred in 207 (5.3%) patients. Adjusted hazard ratio (HR) was higher in the lowest (<2.26 mg/L, HR: 1.90, 95% confidence interval (CI): 1.08-3.33; P=0.025), second highest (10.16-12.56 mg/L, HR: 1.86, 95% CI: 1.09-3.16; P=0.023), and highest quintiles (≥12.56 mg/L, HR: 2.02, 95% CI: 1.21-3.36; P=0.007) of postprocedural hsCRP, compared to the second lowest quintile (2.26-4.85 mg/L). RCS analysis depicted a J-shaped association between postprocedural hsCRP and mortality (P for nonlinearity=0.004). Similar association was observed between hsCRP and cardiac death (P for nonlinearity=0.014), but not for noncardiac mortality (P for nonlinearity=0.228). Conclusions. Both low and high postprocedural hsCRP were associated with higher risk of death in ACS patients treated by PCI. |
format | Article |
id | doaj-art-a209338591144d6ead00abc80d28dee9 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-a209338591144d6ead00abc80d28dee92025-02-03T01:05:02ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/93434759343475Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary InterventionRunzhen Chen0Chen Liu1Peng Zhou2Yu Tan3Zhaoxue Sheng4Jiannan Li5Jinying Zhou6Yi Chen7Li Song8Hanjun Zhao9Hongbing Yan10Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaBackground. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association between postprocedural hsCRP and mortality in patients with acute coronary syndromes (ACS) treated by percutaneous coronary intervention (PCI). Methods. A total of 3940 consecutive ACS patients treated by PCI with postprocedural hsCRP measurements were retrospectively recruited. Patients were stratified into 5 groups according to quintiles of hsCRP. Cox regression with adjustments for multiple covariates was used for outcome analysis. Restricted cubic spline (RCS) analysis was used to allow possible nonlinear associations. The primary outcome was all-cause death. Results. During a median follow-up of 727 days, mortality occurred in 207 (5.3%) patients. Adjusted hazard ratio (HR) was higher in the lowest (<2.26 mg/L, HR: 1.90, 95% confidence interval (CI): 1.08-3.33; P=0.025), second highest (10.16-12.56 mg/L, HR: 1.86, 95% CI: 1.09-3.16; P=0.023), and highest quintiles (≥12.56 mg/L, HR: 2.02, 95% CI: 1.21-3.36; P=0.007) of postprocedural hsCRP, compared to the second lowest quintile (2.26-4.85 mg/L). RCS analysis depicted a J-shaped association between postprocedural hsCRP and mortality (P for nonlinearity=0.004). Similar association was observed between hsCRP and cardiac death (P for nonlinearity=0.014), but not for noncardiac mortality (P for nonlinearity=0.228). Conclusions. Both low and high postprocedural hsCRP were associated with higher risk of death in ACS patients treated by PCI.http://dx.doi.org/10.1155/2020/9343475 |
spellingShingle | Runzhen Chen Chen Liu Peng Zhou Yu Tan Zhaoxue Sheng Jiannan Li Jinying Zhou Yi Chen Li Song Hanjun Zhao Hongbing Yan Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention Mediators of Inflammation |
title | Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention |
title_full | Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention |
title_fullStr | Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention |
title_full_unstemmed | Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention |
title_short | Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention |
title_sort | both low and high postprocedural hscrp associate with increased risk of death in acute coronary syndrome patients treated by percutaneous coronary intervention |
url | http://dx.doi.org/10.1155/2020/9343475 |
work_keys_str_mv | AT runzhenchen bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT chenliu bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT pengzhou bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT yutan bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT zhaoxuesheng bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT jiannanli bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT jinyingzhou bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT yichen bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT lisong bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT hanjunzhao bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention AT hongbingyan bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention |